Peter Pin-Sung Liu
Overview
Explore the profile of Peter Pin-Sung Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsai H, Lin Y, Yeh J, Lin S, Liu P, Chang Y, et al.
Invest Ophthalmol Vis Sci
. 2024 Jun;
65(6):19.
PMID: 38864813
Purpose: The purpose of this study was to evaluate the risk of newly diagnosed retinal vein occlusion (RVO) in patients with type 2 diabetes (T2D) using sodium-glucose cotransporter-2 inhibitors (SGLT-2i)...
2.
Liu P, Chang H, Hsu J, Huang H, Loh C, Yeh J
Sci Rep
. 2024 Apr;
14(1):8892.
PMID: 38632335
There is a lack of studies that concurrently differentiate the effect of the holiday season from the weekend effect on mortality risk in patients with acute myocardial infarction (AMI). We...
3.
Huang H, Chuang A, Liao T, Shao S, Liu P, Tu Y, et al.
JAMA Netw Open
. 2024 Feb;
7(2):e2354734.
PMID: 38335002
Importance: Denosumab, a humanized monoclonal antibody against receptor activator of nuclear factor κB ligand (RANKL), is a widely used antiresorptive medication for osteoporosis treatment. Recent preclinical studies indicate that inhibition...
4.
Liu P, Chang J, Hsu J, Huang H, Loh C, Yeh J
Korean Circ J
. 2024 Feb;
54(3):126-137.
PMID: 38324232
Background And Objectives: The impact of off-hours admission (such as weekends, nighttime, and non-working hours) vs. regular hours (weekdays and daytime working hours) on the mortality risk of patients undergoing...
5.
Tsai H, Lin Y, Yeh J, Huang Y, Liu P, Peng C, et al.
Diabetes Metab Res Rev
. 2023 Oct;
40(2):e3739.
PMID: 37862117
Aims: Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have off-target effects on haemoconcentration and anti-inflammation. The impact of SGLT-2i on the risk of venous thromboembolism (VTE) in patients with diabetes mellitus (DM) remains...
6.
Huang H, Liu P, Lin S, Yeh J, Hsu J, Peng C, et al.
Eur Heart J Cardiovasc Pharmacother
. 2023 May;
9(5):427-434.
PMID: 37218689
Aims: Evidence regarding the risks of serious hypoglycaemia for patients with atrial fibrillation (AF) and diabetes mellitus (DM) taking antidiabetic medications with concurrent non-vitamin K antagonist oral anticoagulants (NOACs) vs....
7.
Lin S, Liu P, Tu Y, Lai E, Yeh J, Hsu J, et al.
Cardiovasc Diabetol
. 2023 Jan;
22(1):1.
PMID: 36609317
Background: Heart failure (HF) is a critical complication in elderly patients with atrial fibrillation (AF) and diabetes mellitus (DM). Recent preclinical studies suggested that non-vitamin K antagonist oral anticoagulants (NOACs)...
8.
Hsu J, Liu P, Liu A, Huang H, Loh C
J Am Heart Assoc
. 2022 Nov;
11(22):e027178.
PMID: 36326053
Background Patients with type A aortic dissection (TAAD) have a high short-term risk of stroke. However, whether patients with TAAD have an increased long-term risk of stroke is still undetermined,...
9.
Hsu J, Liu P, Sposato L, Huang H, Liu A, Lai E, et al.
Front Cardiovasc Med
. 2022 Aug;
9:929304.
PMID: 35935644
Background: Atrial fibrillation detected after stroke (AFDAS) has a lower risk of ischemic stroke recurrence than known atrial fibrillation (KAF). While the benefit of oral anticoagulants (OAC) for preventing ischemic...
10.
Wei W, Lin S, Hsu J, Wu Y, Loh C, Huang H, et al.
J Pers Med
. 2022 Feb;
12(2).
PMID: 35207789
Background: Previous studies in Western countries have shown that a hyperosmolar hyperglycemic state (HHS) is associated with an increased risk of venous thromboembolism (VTE); in these cases, prophylactic anticoagulant treatment...